Bio-Rad Laboratories Pre-Tax Profit Margin 2010-2023 | BIO
Current and historical pre-tax profit margin for Bio-Rad Laboratories (BIO) from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Bio-Rad Laboratories pre-tax profit margin for the three months ending December 31, 2023 was .
| Bio-Rad Laboratories Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-12-31 | $2.67B | $-0.85B | -31.82% |
| 2023-09-30 | $2.72B | $-0.19B | -6.88% |
| 2023-06-30 | $2.77B | $-0.53B | -19.18% |
| 2023-03-31 | $2.78B | $-0.25B | -9.03% |
| 2022-12-31 | $2.80B | $-4.70B | -167.88% |
| 2022-09-30 | $2.81B | $-7.82B | -278.86% |
| 2022-06-30 | $2.87B | $-2.59B | -90.32% |
| 2022-03-31 | $2.90B | $-0.22B | -7.46% |
| 2021-12-31 | $2.92B | $5.45B | 186.42% |
| 2021-09-30 | $2.98B | $8.57B | 287.42% |
| 2021-06-30 | $2.88B | $5.23B | 181.49% |
| 2021-03-31 | $2.70B | $5.32B | 196.82% |
| 2020-12-31 | $2.55B | $4.92B | 193.17% |
| 2020-09-30 | $2.38B | $4.53B | 190.25% |
| 2020-06-30 | $2.29B | $2.51B | 109.37% |
| 2020-03-31 | $2.33B | $2.03B | 87.25% |
| 2019-12-31 | $2.31B | $2.26B | 97.79% |
| 2019-09-30 | $2.31B | $0.52B | 22.60% |
| 2019-06-30 | $2.29B | $1.21B | 52.69% |
| 2019-03-31 | $2.29B | $0.78B | 33.86% |
| 2018-12-31 | $2.29B | $0.51B | 22.40% |
| 2018-09-30 | $2.29B | $1.60B | 69.75% |
| 2018-06-30 | $2.28B | $1.28B | 56.11% |
| 2018-03-31 | $2.21B | $0.94B | 42.59% |
| 2017-12-31 | $2.16B | $0.10B | 4.54% |
| 2017-09-30 | $2.11B | $0.02B | 1.14% |
| 2017-06-30 | $2.09B | $0.02B | 0.77% |
| 2017-03-31 | $2.10B | $0.04B | 2.00% |
| 2016-12-31 | $2.07B | $0.04B | 2.03% |
| 2016-09-30 | $2.07B | $0.12B | 6.00% |
| 2016-06-30 | $2.03B | $0.13B | 6.21% |
| 2016-03-31 | $2.02B | $0.14B | 6.89% |
| 2015-12-31 | $2.02B | $0.15B | 7.23% |
| 2015-09-30 | $2.05B | $0.14B | 6.74% |
| 2015-06-30 | $2.11B | $0.14B | 6.40% |
| 2015-03-31 | $2.14B | $0.14B | 6.73% |
| 2014-12-31 | $2.18B | $0.13B | 6.07% |
| 2014-09-30 | $2.18B | $0.13B | 6.01% |
| 2014-06-30 | $2.15B | $0.10B | 4.83% |
| 2014-03-31 | $2.14B | $0.10B | 4.86% |
| 2013-12-31 | $2.13B | $0.11B | 5.30% |
| 2013-09-30 | $2.10B | $0.13B | 6.23% |
| 2013-06-30 | $2.10B | $0.19B | 9.10% |
| 2013-03-31 | $2.08B | $0.21B | 9.99% |
| 2012-12-31 | $2.07B | $0.23B | 11.12% |
| 2012-09-30 | $2.05B | $0.25B | 12.27% |
| 2012-06-30 | $2.06B | $0.25B | 12.22% |
| 2012-03-31 | $2.08B | $0.24B | 11.76% |
| 2011-12-31 | $2.07B | $0.25B | 11.86% |
| 2011-09-30 | $2.06B | $0.22B | 10.64% |
| 2011-06-30 | $2.01B | $0.22B | 10.98% |
| 2011-03-31 | $1.96B | $0.22B | 11.13% |
| 2010-12-31 | $1.93B | $0.22B | 11.41% |
| 2010-09-30 | $1.89B | $0.21B | 10.85% |
| 2010-06-30 | $1.88B | $0.20B | 10.54% |
| 2010-03-31 | $1.84B | $0.19B | 10.45% |
| 2009-12-31 | $1.78B | $0.19B | 10.37% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $8.136B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.688B | 24.51 |
| Stryker (SYK) | United States | $127.423B | 31.59 |
| Medtronic (MDT) | Ireland | $107.939B | 15.28 |
| Boston Scientific (BSX) | United States | $101.215B | 33.65 |
| EssilorLuxottica (ESLOY) | France | $99.656B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.872B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 30.04 |
| ResMed (RMD) | United States | $27.097B | 27.09 |
| Terumo (TRUMY) | Japan | $25.416B | 35.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.968B | 16.07 |
| Baxter (BAX) | United States | $20.831B | 15.19 |
| Koninklijke Philips (PHG) | Netherlands | $19.511B | 15.56 |
| Insulet (PODD) | United States | $11.713B | 61.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.842B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.357B | 39.56 |
| Lantheus Holdings (LNTH) | United States | $4.415B | 11.40 |
| Haemonetics (HAE) | United States | $4.320B | 22.10 |
| Perrigo (PRGO) | Ireland | $4.132B | 11.82 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.536B | 16.72 |
| Envista Holdings (NVST) | United States | $3.475B | 13.22 |
| QuidelOrtho (QDEL) | United States | $2.702B | 9.81 |
| Neogen (NEOG) | United States | $2.666B | 25.65 |
| Green Thumb Industries (GTBIF) | United States | $2.566B | 81.33 |
| ICU Medical (ICUI) | United States | $2.382B | 17.77 |
| TG Therapeutics (TGTX) | United States | $2.202B | 712.50 |
| Owens & Minor (OMI) | United States | $1.959B | 18.80 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.941B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.788B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.662B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.475B | 45.95 |
| InMode (INMD) | Israel | $1.459B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.442B | 47.58 |
| Warby Parker (WRBY) | United States | $1.318B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.81 |
| AtriCure (ATRC) | United States | $1.121B | 0.00 |
| MacroGenics (MGNX) | United States | $1.015B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.905B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.701B | 15.15 |
| Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
| Evolus (EOLS) | United States | $0.678B | 0.00 |
| Quanterix (QTRX) | United States | $0.616B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.551B | 11.94 |
| Jin Medical (ZJYL) | China | $0.543B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.492B | 0.00 |
| PetIQ (PETQ) | United States | $0.489B | 18.24 |
| ZimVie (ZIMV) | United States | $0.437B | 26.75 |
| OraSure Technologies (OSUR) | United States | $0.423B | 7.00 |
| Biote (BTMD) | United States | $0.415B | 3.95 |
| Aurora Cannabis (ACB) | Canada | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 41.42 |
| Zynex (ZYXI) | United States | $0.362B | 41.70 |
| Viemed Healthcare (VMD) | United States | $0.312B | 31.00 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.273B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 14.78 |
| Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
| Veru (VERU) | United States | $0.187B | 0.00 |
| Omeros (OMER) | United States | $0.179B | 0.00 |
| High Tide (HITI) | Canada | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.164B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.152B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.132B | 66.41 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.70 |
| InterCure (INCR) | Israel | $0.118B | 20.00 |
| Fonar (FONR) | United States | $0.101B | 8.70 |
| Cellectar Biosciences (CLRB) | United States | $0.100B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.086B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.080B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.04 |
| Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.54 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 75.27 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |